Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience.
Karakaya MF, Er E, Kırımker O, Gümüşsoy M, Bodakçi E, Özercan M, Doğanay Erdoğan B, Gökcan H, Koloğlu M, Karayalçın K, Yurdaydın C, Tüzüner A, Haznedaroğlu S, Çınar K, Özkan H, Idilman R. Karakaya MF, et al. Among authors: gumussoy m. Turk J Gastroenterol. 2023 Feb;34(2):177-181. doi: 10.5152/tjg.2023.22724. Turk J Gastroenterol. 2023. PMID: 36843302 Free PMC article.
Natural History of Cirrhosis: Changing Trends in Etiology Over the Years.
Idilman R, Aydogan M, Oruncu MB, Kartal A, Elhan AH, Ellik Z, Gumussoy M, Er R, Ozercan M, Duman S, Toruner M, Cinar K, Soykan I, Beyler AR, Ozkan H. Idilman R, et al. Among authors: gumussoy m. Dig Dis. 2021;39(4):358-365. doi: 10.1159/000512746. Epub 2020 Nov 3. Dig Dis. 2021. PMID: 33142287
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Quach NE, Tu X, Zhang X, Noureddin M, Allen AM, Loomba R. Ajmera V, et al. Among authors: gumussoy m. Gastroenterology. 2022 Oct;163(4):1079-1089.e5. doi: 10.1053/j.gastro.2022.06.073. Epub 2022 Jul 2. Gastroenterology. 2022. PMID: 35788349 Free PMC article.
Characteristics of patients with hepatocellular carcinoma: A multicenter study.
Guzelbulut F, Karaogullarindan U, Akkiz H, Altintas E, Demirtas CO, Bahadir O, Keklikkiran C, Yildirim AE, Gumussoy M, Balci HR, Gokcen P, Gokce DT, Simsek C, Turan I, Can G, Gokbulut V, Yaras S, Adali G, Akdogan RA, Avcioglu U, Demir M, Doganay HL, Vatansever S, Sumer H, Dilber F, Kayhan MA, Balaban HY, Simsek H, Ozdogan OC, Akarca US, Karasu Z, Gunsar F, Idilman R. Guzelbulut F, et al. Among authors: gumussoy m. Hepatol Forum. 2022 Sep 23;3(3):71-76. doi: 10.14744/hf.2022.2022.0028. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177097 Free PMC article.
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK, Bergstrom J, Loomba R, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Truong E, Yang JD, Noureddin M, Allen AM, Loomba R, Ajmera V. Kim BK, et al. Among authors: gumussoy m. Hepatology. 2023 Dec 1;78(6):1858-1866. doi: 10.1097/HEP.0000000000000470. Epub 2023 May 22. Hepatology. 2023. PMID: 37203233 Free PMC article. Clinical Trial.
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. Huang DQ, et al. Among authors: gumussoy m. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4. Lancet Gastroenterol Hepatol. 2023. PMID: 37419133 Free PMC article.
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
Duman S, Kuru D, Gumussoy M, Kiremitci S, Gokcan H, Ulas B, Ellik Z, Ozercan M, Er RE, Karakaya F, Bodakci E, Erden A, Elhan AH, Savas B, Loomba R, Idilman R. Duman S, et al. Among authors: gumussoy m. Eur Radiol. 2024 Jun;34(6):3882-3888. doi: 10.1007/s00330-023-10441-5. Epub 2023 Nov 21. Eur Radiol. 2024. PMID: 37987833
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. Noureddin N, et al. Among authors: gumussoy m. Aliment Pharmacol Ther. 2024 Jun;59(12):1521-1526. doi: 10.1111/apt.17981. Epub 2024 Apr 3. Aliment Pharmacol Ther. 2024. PMID: 38571305
52 results